Xeris Pharmaceuticals

Therapeutics
Therapeutics
Current

Initial Transaction Details

Transaction Date
December 2015
Purpose of Financing
Venture
Stage of Company
Mid Stage
Structure of Financing
Equity

Xeris is a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies.

Website